乳腺癌中化疗诱导的外周神经病变的预测因素:一个决策树模型方法
Juan Adrian Wiranata1, Yufi Kartika Astari2, Meita Ucche3
1Universitas Gadjah Mada Academic Hospital, Yogyakarta, Indonesia.
JCO global oncology
|November 14, 2024
概括
化疗诱导的周围神经病变 (CIPN) 影响了许多乳腺癌患者. 基线C反应蛋白 (CRP),BMI和婚姻状况预测CIPN,有助于识别不太可能发展这种疾病的患者.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 生物统计学 生物统计学
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 显著影响乳腺癌患者的生活质量.
- 确定CIPN的预测因子对于主动管理和患者护理至关重要.
研究的目的:
- 在接受化疗的乳腺癌患者中开发CIPN发生的预测模型.
- 为了利用CIPN预测的分类和回归树 (CART) 算法.
主要方法:
- 一项涉及170名接受化疗的乳腺癌患者的前性研究.
- 患者报告的结果使用常用术语标准对不良事件 (CTCAE) v4.0来评估CIPN.
- 分类和回归树 (CART) 模型具有10倍的交叉验证,以确定基线预测因素.
主要成果:
- CIPN的流行率为64.7%.
- 通过CART模型识别的关键预测因素包括C反应性蛋白 (CRP) 水平 (>3.91 mg/dL),体重指数 (BMI) (>21.85 kg/m2) 和未婚婚姻状况.
- 卡特模型的准确性为65.9%,AUC为0.705,更好地排除不会发展CIPN的个体.
结论:
- 基线CRP,中性粒细胞与淋巴细胞比率 (NLR),BMI和婚姻状况是CIPN的重要预测因素.
- 卡特模型为CIPN提供了个性化患者护理和预防策略的潜力.
- 该模型显示在识别患有CIPN风险较低的患者时具有实用性.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Survival Tree
61
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
61
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


